Navigation Links
Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission
Date:3/26/2009

based on Thoratec's current expectations, estimates, forecasts and projections. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: Failure of HeartWare's stockholders to approve the proposed transaction; the challenges and costs of closing, integrating, restructuring and achieving anticipated synergies; the ability to retain key employees; and other economic, business, competitive, and/or regulatory factors affecting the businesses of Thoratec and HeartWare generally, including those set forth in the filings of Thoratec and HeartWare with the Securities and Exchange Commission (the "SEC"), especially in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of their respective annual reports on Form 10-K and quarterly reports on Form 10-Q, their current reports on Form 8-K and other SEC filings. These forward-looking statements speak only as of the date hereof. Thoratec undertakes no obligation to publicly release the results of any revisions or updates to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.

Additional Information and Where You Can Find It

Thoratec will file a Registration Statement on Form S-4 containing a proxy statement/prospectus and other documents concerning the proposed acquisition and HeartWare will file a proxy statement and other documents concerning the acquisition, in each case with the SEC. Investors are urged to read the proxy statement/prospectus when it becomes available and other relevant documents filed with the SEC because they will contain important information. Security holders may obtain a free copy of the proxy statement/prospectus (when it is available) and other documents filed by Thoratec and HeartWare with the SEC at
'/>"/>

SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Thoratec Presentation at Raymond James Conference to Be Webcast
2. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
3. Thoratec Reports 34 Percent Increase in 2008 Revenues
4. Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
5. Thoratec Presentation at Piper Jaffary Conference to be Webcast
6. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
7. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
8. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
9. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
10. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
11. Thoratecs ITC Division Receives FDA Warning Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- The risk of ... holidays, so you need to be extra cautious, an ... we see a significant increase in patients coming in ... the Suffolk County Volunteer Firefighters Burn Center of Stony ... should be full of joy, but if not careful, ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, ... a "fountain of youth" drug that can delay the effects ... new study suggests. Seniors received a significant boost to ... genetic signaling pathway linked to aging and immune function, researchers ... experimental medication, a version of the drug rapamycin, improved the ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as part ... mobile applications on the iOS, Android, and Windows markets. Andrew ... the app review and shared with viewers how this is ... old saying goes, “A picture says a thousand words.” It’s ... a single image, because each picture holds a unique and ...
(Date:12/25/2014)... Each year trauma accounts for approximately ... admissions across the nation (according to the Centers ... National Hospital Ambulatory Medical Care Survey collected data ... 2010. They estimated that there were between 3.5 and ... primary diagnosis of broken bone or fracture. , ...
(Date:12/24/2014)... (PRWEB) December 25, 2014 Over 700 ... to their local communities. That is 700 smiling little ... single gift. Additionally over $6000 in monetary donations was ... offset some of the expenses they incur through the ... drive were A Child's Haven , Shrine's Children's ...
Breaking Medicine News(10 mins):Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4Health News:AlignLife Donates Over 700 Toys This Year 2
... News) -- Exposure to secondhand smoke could affect hearing ... loss during adolescence, a new study indicates. These ... exposed to secondhand smoke, the researchers warned. Roughly ... exposed to secondhand smoke, reported the study,s authors. These ...
... HealthDay Reporter , MONDAY, July 18 (HealthDay ... blood pressure modestly among hypertensive patients, a small, new ... refined carbohydrates -- such as white bread and white ... protein "might be an important component of nutrition intervention ...
... JULY 18, 2011 Registration is now open for ... the Cardiovascular Research Foundation, which will return to San ... year, groundbreaking scientific advances in interventional cardiology presented at ... cause of death in the United States, is viewed ...
... journal Science Signaling Van Andel Research Institute ... anti-malaria drug chloroquine represses inflammation, which may provide a ... multitude of autoimmune diseases such as arthritis, multiple sclerosis, ... anti-malaria drug that inhibits the growth of parasites. For ...
... Researchers at Mount Sinai School of Medicine have identified how ... diabetes, also possibly kills nerve cells in the brain, thereby ... the generation of amyloid-beta (Abeta) in the brain. Abeta plays ... researchers previously linked SorCS1 to Alzheimer,s disease and identified where ...
... pace of translating science into real-life solutions for patients ... Health to expand its work over the next five ... (CTSI) is among 10 institutes nationwide to receive the ... first five years of the NIH,s Clinical and Translational ...
Cached Medicine News:Health News:Secondhand Smoke Linked to Hearing Loss in Teens 2Health News:Small Study Suggests Milk, Soy Proteins Lower Blood Pressure Modestly 2Health News:Small Study Suggests Milk, Soy Proteins Lower Blood Pressure Modestly 3Health News:Innovations in cardiovascular therapies and treatments will be presented at TCT 2011 2Health News:Chloroquine finding may lead to treatments for arthritis, cancer and other diseases 2Health News:Chloroquine finding may lead to treatments for arthritis, cancer and other diseases 3Health News:Researchers identify how a gene linked to both Alzheimer's disease and type 2 diabetes works 2Health News:UCSF receives $112 million to help translate science into cures 2Health News:UCSF receives $112 million to help translate science into cures 3Health News:UCSF receives $112 million to help translate science into cures 4
(Date:12/24/2014)... 2014   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today announced validation ... Marketing Authorization Application (MAA) for sebelipase alfa for ... request for accelerated assessment, which has the potential ... The MAA, and the Biologics License ...
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin ... company that specializes in patented biopharmaceutical, modernized traditional ... ingredients (API) today announced that the Company achieved ... Good Manufacturing Practice (GMP) certificate of TPI,s Qionglai ... Administration,s (CFDA). The public notice period is a ...
(Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... BRANFORD, Connecticut, June 15, 2011 , ... has killed dozens and,hospitalized thousands across Europe has been ... to generate the,"most accurate and detailed genetic analysis to ... ] ,The sequencing was performed by scientists at the ...
... Systems, Inc. (NYSE: VAR ), the world,s ... radiotherapy, announced today it has received Shonin approval from ... to market the TrueBeam™ system for image-guided radiotherapy and ... breast, prostate, head and neck, and other types of ...
Cached Medicine Technology:Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 2Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date 3TrueBeam™ System for Non-Invasive Image-Guided Cancer Treatment Receives Shonin Approval 2TrueBeam™ System for Non-Invasive Image-Guided Cancer Treatment Receives Shonin Approval 3
When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator., ,Most Appropriate for the Proximal Femur, Metatarsal/Tarsal...
... Siemens Medical Solutions introduces its new ... system with intuitive patient data management ... lithotripter and urological table. Lithoskop is ... urodiagnostics that covers all applications like ...
... bone growth stimulator for the treatment of ... bone growth stimulator is a useful adjunct ... is already planned or when patient compliance ... is totally surgically implanted, patients are assured ...
... cataract surgery following refractive surgery grows larger ... for surgeons, as calculating IOL power for ... power following RK, ALK, PRK and LASIK ... or topography. For example, keratometry and simulated ...
Medicine Products: